Increasing health burden of human babesiosis in endemic sites

被引:144
作者
Krause, PJ
McKay, K
Gadbaw, J
Christianson, D
Closter, L
Lepore, T
Telford, SR
Sikand, V
Ryan, R
Persing, D
Radolf, JD
Spielman, A
机构
[1] Connecticut Childrens Med Ctr, Hartford, CT 06106 USA
[2] Univ Connecticut, Sch Med, Dept Pediat, Hartford, CT 06112 USA
[3] Univ Connecticut, Sch Med, Dept Med, Hartford, CT 06112 USA
[4] Block Isl Med Ctr, Block Isl, RI 02807 USA
[5] Nantucket Cottage Hosp, Nantucket, MA 02554 USA
[6] Corixa Corp, Seattle, WA 98104 USA
[7] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[8] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.4269/ajtmh.2003.68.431
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Human infection due to Babesia microti has been regarded as infrequent and a condition primarily affecting the elderly or immunocompromised. To determine whether risk in endemic sites may be increasing relative to that of Borrelia burgdorferi and to define its age-related clinical spectrum, we carried out a 10-year community-based serosurvey and case finding study on Block Island, Rhode Island. Less intensive observations were conducted in nearby sites. Incidence of babesial infection on Block Island increased during the early 1990s, reaching a level about three-fourths that of borrelial infection. The sera of approximately one-tenth of Block Island residents reacted against babesial antigen, a seroprevalence similar to those on Prudence Island and in southeastern Connecticut. Although the number and duration of babesial symptoms in people older than 50 years of age approximated those in people 20 to 49 years of age, more older adults were admitted to hospital than younger adults. Few Babesia-infected children were hospitalized. Babesial incidence at endemic sites in southern New England appears to have risen during the 1990s to a level approaching that due to borreliosis.
引用
收藏
页码:431 / 436
页数:6
相关论文
共 47 条
[1]  
BUSH JB, 1990, S AFR MED J, V78, P699
[2]  
Campbell GL, 1998, AM J EPIDEMIOL, V148, P1018, DOI 10.1093/oxfordjournals.aje.a009568
[3]  
CARTTER ML, 2000, CONN EPIDEMIOL, V21, P9
[4]  
*CDCP, 1990, MMWR-MORBID MORTAL W, V39, P19
[5]  
*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P181
[6]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P533
[7]  
Centers for Disease Control and Prevention, 1995, MORB MORTAL WKLY RE, V44, P590
[8]   The public health impact of Lyme disease in Maryland [J].
Coyle, BS ;
Strickland, GT ;
Liang, YY ;
Pena, C ;
McCarter, R ;
Israel, E .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) :1260-1262
[9]   THE RISING INCIDENCE OF CLINICAL BABESIA-MICROTI INFECTION [J].
DAMMIN, GJ ;
SPIELMAN, A ;
BENACH, JL ;
PIESMAN, J .
HUMAN PATHOLOGY, 1981, 12 (05) :398-400
[10]   WESTERN BLOTTING IN THE SERODIAGNOSIS OF LYME-DISEASE [J].
DRESSLER, F ;
WHALEN, JA ;
REINHARDT, BN ;
STEERE, AC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) :392-400